krn23
Showing 1 - 9 of 9
Tumor-Induced Osteomalacia (TIO) Trial in Beijing, Chengdu, Shanghai (KRN23)
Recruiting
- Tumor-Induced Osteomalacia (TIO)
- KRN23
-
Beijing, China
- +2 more
Sep 10, 2022
XLH Trial in Japan, Korea, Republic of (KRN23)
Completed
- XLH
- KRN23
-
Sapporo, Hokkaido, Japan
- +9 more
Sep 1, 2022
X-linked Hypophosphatemia (XLH) Trial in Beijing, Guangzhou, Shanghai (KRN23)
Recruiting
- X-linked Hypophosphatemia (XLH)
- KRN23
-
Beijing, China
- +2 more
Nov 10, 2021
X-linked Hypophosphatemia (XLH) Trial in China (KRN23)
Recruiting
- X-linked Hypophosphatemia (XLH)
- KRN23
-
Beijing, China
- +4 more
Nov 10, 2021
X-linked Hypophosphatemia Trial in Canada, United States (KRN23)
Completed
- X-linked Hypophosphatemia
- KRN23
-
San Francisco, California
- +5 more
Jan 29, 2021
X-linked Hypophosphatemia Trial in Canada, United States (KRN23)
Completed
- X-linked Hypophosphatemia
- KRN23
-
San Francisco, California
- +5 more
Sep 30, 2020
X-linked Hypophosphatemic Rickets/Osteomalacia Trial in Japan (KRN23)
Completed
- X-linked Hypophosphatemic Rickets/Osteomalacia
- KRN23
-
Yokohama, Kanagwa, Japan
- +3 more
May 13, 2020
X-linked Hypophosphatemic Rickets/Osteomalacia Trial in Tokyo, Seoul (KRN23)
Completed
- X-linked Hypophosphatemic Rickets/Osteomalacia
- KRN23
-
Tokyo, Japan
- +1 more
Feb 28, 2017
X-linked Hypophosphatemia Trial in United States (Placebo, KRN23)
Completed
- X-linked Hypophosphatemia
- Placebo
- KRN23
-
New Haven, Connecticut
- +3 more
Oct 18, 2013